Ocular Oncology Service entered the industry of Ophthalmologists in 1966 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 6211110, which describes it as a Ophthalmologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Ophthalmologists. The business provides service to the B2C market.
To acquire more information, please contact Felica Williamson, Office Manager by calling (215) 928-3105 during business hours. You can also write to the business’ Single Location at 840 Walnut St, Philadelphia, Pennsylvania PA 19107. You can also visit the company’s website at eyecancerinfo.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Ocular Oncology Service |
Representative: | Felica Williamson, Office Manager |
Place of Business: | 840 Walnut St, Philadelphia, PA 19107 |
Contact Number: | (215) 928-3105 |
Website: | eyecancerinfo.com |
Type of Service: | Ophthalmologists |
SIC Number: | 8011 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 1966 |
Income/Year: | $5.000.000 to $9.999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Ocular Oncology Service is a company operating from Philadelphia, Pennsylvania providing professional Ophthalmologists and relevant B2C variables. It was founded in 1966 and registered with the SIC code 8011 as Ophthalmologists, and with the NAICS code 6211110 as Ophthalmologists.
With a current employee count of 1 to 4, Ocular Oncology Service has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Felica Williamson, Office Manager at (215) 928-3105 for related queries, or to locate its Single Location using the coordinates 39.94814,-75.15493.
The Single Location can also be found at the street address 840 Walnut St in Philadelphia, Pennsylvania 19107 and can be engaged online through the company website at eyecancerinfo.com, the company Twitter , and Facebook page .